Coagulation-related factors, thrombomodulin and protein Z, are not associated with risk for oral cancer

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2449-2451

  Vairaktaris, Eleftherios ^a   Serefoglou, Zoe ^a   Yapijakis, Christos ^a   Nkenke, Emeka ^b   Vassiliou, Stavros ^a   Spyridonidou, Sofia ^a   Vylliotis, Antonis ^a   Nixon, Alexander Michael ^a   Neukam, Friedrich Wilhelm ^b   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Genetic association study; Oral oncogenesis; Polymorphism; Protein Z; Thrombin; Thrombomodulin

Indexed keywords

FATTY ACID BINDING PROTEIN; THROMBOMODULIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BLOOD PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; THROMBOMODULIN;

EID: 34547812138     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Rickles FR and Falanga A: Molecular basis for the relationship between thrombosis and cancer. Thromb Res 102: V215-224, 2001.
2. Vairaktaris E, Yapijakis C, Kessler P, Vylliotis A, Ries J, Wiltfang J, Vassiliou S, Derka S and Neukam FW: Methylene-tetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132: 219-222, 2006.
3. Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P and Neukam FW: Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42: 888-892, 2006.
4. Vairaktaris E, Yapijakis C, Wiltfang J, Ries J, Vylliotis A, Derka S, Vasiliou S and Neukam FW: Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res 25: 2561-2565, 2005.
5. Broze GJ Jr: Protein Z-dependent regulation of coagulation. Thromb Haemost 86: 8-13, 2001.
6. Hanly AM, Hayanga A, Winter DC and Bouchier-Hayes DJ: Thrombomodulin: tumour biology and prognostic implications. Eur J Surg Oncol 31: 217-220, 2005.
7. Tabata M, Yonezawa S, Sugihara K, Yamashita S and Maruyama I: The use of thrombomodulin to study epithelial cell differentiation in neoplastic and non-neoplastic oral lesions. J Oral Pathol Med 24: 443-449, 1995.
8. Le Flem L, Picard V, Emmerich J, Gandrille S, Fiessinger JN, Aiach M and Alhenc-Gelas M: Mutations in promoter region of thrombomodulin and venous thromboembolic disease. Arterioscler Thromb Vasc Biol 19: 1098-1104, 1999.
9. Lichy C, Kropp S, Dong-Si T, Genius J, Dolan T, Hampe T, Stoll F, Reuner K, Grond-Ginsbach C and Grau A: A common polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke 35: 40-45, 2004.
10. Liu Y, Gilcrease MZ, Henderson Y, Yuan XH, Clayman GL and Chen Z: Expression of protease-activated receptor 1 in oral squamous cell carcinoma. Cancer Lett 169: 173-180, 2001.